Font Size: a A A
Keyword [CI-1033]
Result: 1 - 1 | Page: 1 of 1
1. The combination of pan-ErbB tyrosine kinase inhibitor CI-1033 and lovastatin: A potential novel therapeutic approach in squamous cell carcinoma of the head and neck
  <<First  <Prev  Next>  Last>>  Jump to